Vertex Pharmaceuticals (VRTX)
NASDAQHealth CareBiotechnologySnapshot 2026-07-08
$498.43-4.56%
Close 2026-07-08 · 1-day change
Reading VRTX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VRTX free→NASDAQHealth CareBiotechnologySnapshot 2026-07-08
Reading VRTX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VRTX free→QuarterlyIQ Insights · VRTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 12,218.0 | 12,001.3 | 11,020.1 | 9,869.2 | 8,930.7 | 7,574.4 | 6,205.7 | 4,162.8 | 1,702.2 | 1,702.2 | 1,702.2 | 1,032.3 | 1,527.0 | 1,527.0 | 1,527.0 | 1,410.6 | 175.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,702.2 | 1,702.2 | 1,032.3 | 1,527.0 | 1,527.0 | 1,527.0 | 1,410.6 | 175.5 |
| Cost of Revenues | 1,681.1 | 1,651.3 | 1,530.5 | 1,262.2 | 1,080.3 | 904.2 | 736.3 | 547.8 | 210.5 | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 1,850.4 | 1,753.1 | 1,464.3 | 1,136.6 | 944.7 | 840.1 | 770.5 | 658.5 | 432.8 | 432.8 | 432.8 | 376.6 | 432.7 | 436.8 | 436.8 | 400.7 | 101.3 |
| R&D Expenses | — | — | — | — | — | 3,051.1 | 1,829.5 | 1,754.5 | 1,047.7 | 1,047.7 | 1,047.7 | 995.9 | 765.9 | 806.2 | 806.2 | 707.7 | 516.9 |
| Operating Income | 4,681.3 | 4,173.3 | (232.9) | 3,832.0 | 4,307.4 | 2,782.1 | 2,856.3 | 1,197.6 | 9.9 | 9.9 | 9.9 | (466.9) | 46.7 | 2.3 | 2.3 | 113.8 | (462.7) |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | — | — | — | 58.2 | 58.5 | — | — | — | — | — | 0.0 | 16.7 | 38.5 | 13.5 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.9 | 1.9 | 16.3 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 14.7 | 36.6 | (2.9) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 2.5 | 0.0 | — | 73.1 | — | — |
| EBT, Incl. Unusual Items | 5,165.7 | 4,643.2 | 248.5 | 4,379.8 | 4,232.4 | 2,730.4 | 3,116.8 | 1,394.9 | (67.4) | (67.4) | (67.4) | (557.8) | 32.0 | (12.4) | (12.4) | 60.4 | (459.9) |
| Income Tax Expense | 827.4 | 690.0 | 784.1 | 760.2 | 910.4 | 388.3 | 405.2 | 218.1 | 16.7 | 16.7 | 16.7 | 30.4 | (0.3) | 38.8 | 38.8 | 19.3 | 0.0 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | (84.0) | (588.2) | 32.3 | — | — | — | — |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | — | — | — | — | 0.0 | 0.0 | 28.0 | 28.0 | (5.2) | (0.9) | (4.2) | 55.9 | 55.9 | 11.6 | — |
| Net Income | 4,338.3 | 3,953.2 | (535.6) | 3,619.6 | 3,322.0 | 2,342.1 | 2,711.7 | 1,176.8 | (112.1) | (112.1) | (112.1) | (556.3) | (107.0) | (107.0) | (107.0) | 29.6 | — |
| Per Share | |||||||||||||||||
| Basic EPS | 17.07 | 15.46 | (2.08) | 14.05 | 12.97 | 9.09 | 10.44 | 4.58 | (0.46) | (0.46) | (0.46) | (2.31) | (0.50) | (0.50) | (0.50) | 0.14 | (3.27) |
| Diluted EPS | 16.93 | 15.32 | (2.08) | 13.89 | 12.82 | 9.01 | 10.29 | 4.51 | (0.46) | (0.46) | (0.46) | (2.31) | (0.50) | (0.50) | (0.50) | 0.14 | (3.27) |
| Revenue per Share | 47.67 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 254.1 | 255.7 | 257.9 | 257.7 | 256.1 | 257.7 | 259.8 | 256.7 | 244.7 | 244.7 | 244.7 | 241.3 | 211.9 | 211.9 | 211.9 | 204.9 | 140.6 |
| Diluted Weighted Avg Shares | 256.3 | 258.0 | 257.9 | 260.5 | 259.1 | 259.9 | 263.4 | 260.7 | 244.7 | 244.7 | 244.7 | 241.3 | 215.3 | 211.9 | 211.9 | 208.8 | 140.6 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 4,383.1 | (25.7) | 4,013.3 | 4,455.7 | 2,907.7 | 2,965.8 | 1,304.5 | 71.3 | 71.3 | 71.3 | (404.5) | 84.9 | 40.5 | 40.5 | 148.9 | (430.5) |
| EBIT | 4,681.3 | 4,173.3 | (232.9) | 3,832.0 | 4,307.4 | 2,782.1 | 2,856.3 | 1,197.6 | 9.9 | 9.9 | 9.9 | (466.9) | 46.7 | 2.3 | 2.3 | 113.8 | (462.7) |
| Effective Tax Rate | 16.0% | 14.9% | 315.5% | 17.4% | 21.5% | 14.2% | 13.0% | 15.6% | -24.7% | -24.7% | -24.7% | -5.4% | -0.9% | -313.0% | -313.0% | 31.9% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.